Abbott Laboratories vs. NewAmsterdam Pharma Company N.V. Ordinary Shares
ABT
Abbott Laboratories
$110.51 +0.53%
VS NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares
$18.90 +0.05%
Abbott Laboratories and NewAmsterdam Pharma Company N.V. Ordinary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | NAMS | |
|---|---|---|
| Market Cap | $190.39 billion | $2.27 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | NAMS | |
|---|---|---|
| Dividend Yield | 2.28% | — |
ABT and NAMS split the dividend factors evenly.
Risk & Sentiment
| ABT | NAMS | |
|---|---|---|
| Short Interest | 0.57% | 0.01% |
NAMS leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, NAMS overview, NAMS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.